Kedrion Biopharma is an international company that collects and fractionates human plasma in order to manufacture and distribute plasma-derived therapeutic products for use in the treatment of serious diseases, conditions and conditions such as haemophilia and immune deficiencies
Data management and statistical consultancy activities relating to clinical trials promoted by Kedrion Biopharma
In conformity with Article 26 of the Legislative Decree of August 5, 2022 and the Guidelines of the Italian Ministry of Health March 28, 2013 and December 20, 2017, the information in this section of the website is intended only for healthcare professionals. By selecting Continue, you declare that you are a healthcare professional, allowing you to continue to access the area dedicated to the ARIA medical device.
In conformity with Article 26 of the Legislative Decree of August 5, 2022 and the Guidelines of the Italian Ministry of Health March 28, 2013 and December 20, 2017, the information in this section of the website is intended only for healthcare professionals. By selecting Continue, you declare that you are a healthcare professional, allowing you to continue to access the area dedicated to the ARIA medical device.
